Access. Intelligence. Excellence
Growing Influence of Consumers has Pharmaceutical Industry Shifting its Marketing Focus from Products to Patients
CHAPEL HILL, N.C., March 20, 2015 /PRNewswire/ -- Success in the pharmaceutical marketplace is no longer determined by physicians and payers alone. The growing influence of patients in starting, sustaining or switching therapies has challenged the pharmaceutical industry to shift its marketing focus from products to patients.
As part of this evolving approach to patient engagement, marketers have learned it's important to educate, communicate and engage patients throughout their experiences with a disease - from awareness to patient empowerment. By mapping the patient journey and employing a consumer marketing program that follows this path, marketing groups can more effectively engage with patients.
Companies are successfully using the "Patient Journey" as a framework for shifting their marketing focus to patients. In crowded markets, many factors influence patient preferences and choices; patient-focused programs and support are increasingly forms of differentiation.
Research and consulting leader Best Practices, LLC undertook a benchmark study, "Patient-Focused Marketing: Engagement Milestones along the Patient Journey," to understand how the growing influence of patients is impacting activities and spend for marketing interactions directed to patients.
Key topics addressed in this report include:
- Investment in Patient-Focused Activities & Programs
- Future Investment Levels in the Patient Journey
- Investment within Patient Marketing, Foundation & Leadership Categories
- Deployment of Patient-Focused Activities & Programs
- Activities Timing Across the Patient Journey
- Best Practices Shared by Benchmark Participants
- Effective Patient Loyalty Programs
- Pitfalls for Patient Marketers to Avoid
Marketing leaders can use this study to evaluate how their patient engagement programs compare with industry averages and trends.
The research is based on a benchmarking survey instrument that engaged 22 leaders at 19 companies. Qualitative data came from in-depth interviews with seven participants. To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1339.htm.
For more information on other recent primary research studies, contact us at 919.403.0251.
For related research, visit our Best Practices, LLC Web site at http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE